Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy (Q80809590)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705197%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705197%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Michelle Shayne

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705197%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Eva Culakova

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705197%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Marek S Poniewierski

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705197%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Debra Wolff

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705197%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

David C Dale

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705197%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Jeffrey Crawford

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705197%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Gary H Lyman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705197%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

1 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705197%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705197%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705197%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705197%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

1611-1620

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705197%20AND%20SRC:MED&resulttype=core&format=json

Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22939

7 January 2021

Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22939

7 January 2021

Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22939

7 January 2021

Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22939

7 January 2021

Dealing with metastatic breast cancer in elderly women: results from a French study on a large cohort carried out by the 'Observatory on Elderly Patients'

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22939

7 January 2021

Risk models for predicting chemotherapy-induced neutropenia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22939

7 January 2021

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22939

7 January 2021

Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22939

7 January 2021

Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis, node-positive, early breast cancer: 10-year follow-up results of the French Adjuvant Study Group 05 randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22939

7 January 2021

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22939

7 January 2021

Use and Outcomes of Adjuvant Chemotherapy in Older Women With Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22939

7 January 2021

Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22939

7 January 2021

CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22939

7 January 2021

CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22939

7 January 2021

Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22939

7 January 2021

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22939

7 January 2021

Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22939

7 January 2021

Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22939

7 January 2021

Identifiers

DOI

10.1002/CNCR.22939

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705197%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference